Impact of Glucagon-like Peptide-1 Receptor Agonists on Intestinal Epithelial Cell Barrier

• Egile Nagusiak: Takizawa Y. (Egilea), Kato A. (Egilea), Onsui A. (Egilea), Kanatanai S. (Egilea), Ishimura A. (Egilea), Kurita T. (Egilea), Nakajima T. (Egilea)
• Formatua: Liburua
• Argitaratua: Sciendo, 2024-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

While many types of diabetes medications are currently available, orally administered formulations of glucagon-like peptide-1 (GLP-1) receptor agonists have recently been launched. Therefore, gastrointestinal epithelial cells will be increasingly exposed to GLP-1 receptor agonists; however, their ef...